ImageneBio (IMA) Earnings Date, Estimates & Call Transcripts $14.04 0.00 (0.00%) As of 04:00 PM Eastern Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ImageneBio Earnings Summary ImageneBio issued Q2 2025 earnings on July 24, 2025, reporting an EPS of -$0.06, which topped the consensus estimate of -$0.14 by $0.08. With a trailing EPS of -$7.68, ImageneBio's earnings are expected to grow next year, from ($0.91) to ($0.82) per share. Q2 2025 Earnings ResourcesQ2 2025 Earnings Report Quarterly Report (10-Q)Powered by Latest Q2 Earnings DateJul. 24EstimatedConsensus EPS (Jul. 24) -$0.14 Actual EPS (Jul. 24) -$0.06 Beat By $0.08 Get ImageneBio Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on ImageneBio and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataIMA Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.IMA Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. ImageneBio Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$2.40-$2.16-$2.28Q2 20252-$2.40-$1.80-$2.10Q3 20252-$2.40-$1.00-$1.70Q4 20252-$2.40-$0.89-$1.65 FY 2025 8 -$9.60 -$5.85 -$7.73 Q1 20261-$0.85-$0.85-$0.85Q2 20261-$0.79-$0.79-$0.79Q3 20261-$0.80-$0.80-$0.80Q4 20261-$0.87-$0.87-$0.87 ImageneBio Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails7/24/2025Q2 2025-$0.14-$0.06+$0.08-$0.06--5/8/2025Q1 2025-$2.52-$2.16+$0.36-$0.18--3/11/2025Q4 2024-$2.76-$2.16+$0.60-$0.19--11/7/2024Q3 2024-$3.24-$2.28+$0.96-$0.17--8/8/2024Q2 2024-$3.72-$3.24+$0.48-$0.26--5/13/2024Q1 2024-$4.80-$3.36+$1.44-$0.23--3/12/2024Q4 2023-$4.92-$4.92--$0.41$2.39M$0.66M11/9/2023Q3 2023-$5.28-$4.80+$0.48-$0.40-- ImageneBio Earnings - Frequently Asked Questions When did ImageneBio announce their last quarterly earnings? ImageneBio (NASDAQ:IMA) last announced its quarterly earning data on Thursday, July 24, 2025. Learn more on IMA's earnings history. Did ImageneBio beat their earnings estimates last quarter? In the previous quarter, ImageneBio (NASDAQ:IMA) reported ($0.06) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.14) by $0.08. Learn more on analysts' earnings estimate vs. IMA's actual earnings. How much revenue does ImageneBio generate each year? ImageneBio (NASDAQ:IMA) has a recorded annual revenue of $3.50 million. How much profit does ImageneBio generate each year? ImageneBio (NASDAQ:IMA) has a recorded net income of -$49.23 million. IMA has generated -$7.68 earnings per share over the last four quarters. What is ImageneBio's EPS forecast for next year? ImageneBio's earnings are expected to grow from ($0.91) per share to ($0.82) per share in the next year. More Earnings Resources from MarketBeat Related Companies TVRD Earnings Date ALLO Earnings Date VOR Earnings Date AARD Earnings Date OGI Earnings Date AVTE Earnings Date CRGX Earnings Date ACIU Earnings Date ALEC Earnings Date SOPH Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles DLocal Stock Soars 43% After Earnings Beat and Raised GuidanceGreen Dot's 30% Rally: Turnaround Takes Off on Explosive EarningsElbit Systems Jumps on Record Earnings and a $1.6B ContractBrinker Serves Up Earnings Beat, Sidesteps Cost PressuresWhy BigBear.ai Stock's Dip on Earnings Can Be an Opportunity CrowdStrike Faces Valuation Test Before Key Earnings ReportPost-Earnings, How Does D-Wave Stack Up Against Quantum Rivals? This page (NASDAQ:IMA) was last updated on 8/20/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredNational 'Stock Market Reset' Coming September 30 (New WH Order)Crash Coming Sept 30? Analysts Warn of New Crisis A new problem on the U.S. power grid is putting millions ...Altimetry | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ImageneBio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ImageneBio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access